The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Disorders of iron metabolism. Part II: iron deficiency and iron overload
Open accessAbstract
Main disorders of iron metabolism: Increased iron requirements, limited external supply, and increased blood loss may lead to iron deficiency (ID) and iron deficiency anaemia. In chronic inflammation, the excess of hepcidin decreases iron absorption and prevents iron recycling, resulting in hypoferraemia and iron restricted erythropoiesis, despite normal iron stores (functional iron deficiency), and finally anaemia of chronic disease (ACD), which can evolve to ACD plus true ID (ACD+ID). In contrast, low hepcidin expression may lead to hereditary haemochromatosis (HH type I, mutations of the HFE gene) and type II (mutations of the hemojuvelin and hepcidin genes). Mutations of transferrin receptor 2 lead to HH type III, whereas those of the ferroportin gene lead to HH type IV. All these syndromes are characterised by iron overload. As transferrin becomes saturated in iron overload states, non-transferrin bound iron appears. Part of this iron is highly reactive (labile plasma iron), inducing free radical formation. Free radicals are responsible for the parenchymal cell injury associated with iron overload syndromes. Role of laboratory testing in diagnosis: In iron deficiency status, laboratory tests may provide evidence of iron depletion in the body or reflect iron deficient red cell production. Increased transferrin saturation and/or ferritin levels are the main cues for further investigation of iron overload. The appropriate combination of different laboratory tests with an integrated algorithm will help to establish a correct diagnosis of iron overload, iron deficiency and anaemia. Review of treatment options: Indications, advantages and side effects of the different options for treating iron overload (phlebotomy and iron chelators) and iron deficiency (oral or intravenous iron formulations) will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Andrews, N. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912233412607 · Cited by 2,130
Wintrobe's clinical hematology.
Lee, G. R. (1981) · Medical Entomology and Zoology · Cited by 1,167
The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?
Beutler, E., & Waalen, J. (2006) · Blood · doi:10.1182/blood-2005-07-3046 · Cited by 970
Serum Transferrin Receptor and Its Ratio to Serum Ferritin in the Diagnosis of Iron Deficiency
Punnonen, K., Irjala, K., & Rajamäki, A. (1997) · Blood · doi:10.1182/blood.v89.3.1052 · Cited by 859
Brittenham, G. M., Griffith, P. M., Nienhuis, A. W., McLaren, C. E., Young, N. S., Tucker, E. E., Allen, C. J., Farrell, D. E., & Harris, J. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310902 · Cited by 829
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Pietrangelo, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.013 · Cited by 615
Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
Kirk, P., Roughton, M., Porter, J. B., Walker, J. M., Tanner, M. A., Patel, J., Wu, D., Taylor, J., Westwood, M. A., Anderson, L. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.874487 · Cited by 597
Biochemical Markers and Hematologic Indices in the Diagnosis of Functional Iron Deficiency
Thomas, C., & Thomas, L. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.7.1066 · Cited by 492
Feder, J. N., Tsuchihashi, Z., Irrinki, A., Lee, V. K., Mapa, F. A., Morikang, E., Prass, C. E., Starnes, S. M., Wolff, R. K., Parkkila, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14025 · Cited by 471
Diagnosis and Management of Iron-Deficiency Anaemia
COOK, J. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.022 · Cited by 452 · cited 3×
“However, it is of little screening value because clinicians rarely consider the presence of ID in patients who are not anaemic, and therefore ID is invariably diagnosed in the laboratory.(3) A normal Hb level with a mean corpuscular Hb (MCH) in the lower limit of normality (normal range 28e35 pg) or an increased red c…”
InfluentialFDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
Lu, M., Cohen, M. H., Rieves, D., & Pazdur, R. (2010) · American Journal of Hematology · doi:10.1002/ajh.21656 · Cited by 443
Theurl, I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., Sonnweber, T., Eberwein, L., Witcher, D. R., Murphy, A. T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195651 · Cited by 421
Muñoz, M., Villar, I., & García-Erce, J. A. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4617 · Cited by 371
Self-citationIron and immunity: a double-edged sword.
Weiss, G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1070.x · Cited by 317
Erythropoietin, iron, and erythropoiesis.
Goodnough, L. T., Skikne, B., & Brugnara, C. (2000) · PubMed · Cited by 310
Erythropoietin, iron, and erythropoiesis
Goodnough, L. T., Skikne, B., & Brugnara, C. (2000) · Blood · doi:10.1182/blood.v96.3.823 · Cited by 300
Erythropoietin, iron, and erythropoiesis
Goodnough, L. T., Skikne, B., & Brugnara, C. (2000) · Blood · doi:10.1182/blood.v96.3.823.015k49_823_833 · Cited by 273
Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states
BRUGNARA, C., SCHILLER, B., & MORAN, J. (2006) · Clinical and Laboratory Haematology · doi:10.1111/j.1365-2257.2006.00812.x · Cited by 263
Common Misconceptions in the Diagnosis and Management of Anemia in Inflammatory Bowel Disease
Gisbert, J. P., & Gomollón, F. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01846.x · Cited by 230 · cited 1×
“15 Early studies indicated that the co-administration of iron with vitamin C might be of bene fi t in enhancing iron absorption, since, in theory, more ferrous iron is maintained in solution.”
Beguin, Y., Clemons, G., Pootrakul, P., & Fillet, G. (1993) · Blood · doi:10.1182/blood.v81.4.1067.1067 · Cited by 227
Parenteral iron therapy options
Silverstein, S. B., & Rodgers, G. M. (2004) · American Journal of Hematology · doi:10.1002/ajh.20056 · Cited by 217
Perioperative anaemia management: consensus statement on the role of intravenous iron
Beris, P., Muñoz, M., García-Erce, J. A., Thomas, D., Maniatis, A., & Van der Linden, P. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen054 · Cited by 215
Self-citationStructure, chemistry, and pharmacokinetics of intravenous iron agents.
Danielson, B. G. (2004) · PubMed · doi:10.1097/01.asn.0000143814.49713.c5 · Cited by 208
Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis
Muñoz, M., García-Erce, J. A., & Remacha, Á. F. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.079046 · Cited by 200
Self-citationConsensus statement on iron overload in myelodysplastic syndromes
Bennett, J. M. (2008) · American Journal of Hematology · doi:10.1002/ajh.21269 · Cited by 198
Adams, P. C., & Barton, J. C. (2010) · Blood · doi:10.1182/blood-2010-01-261875 · Cited by 192
Morrison, E. D., Brandhagen, D. J., Phatak, P. D., Barton, J. C., Krawitt, E. L., El-Serag, H. B., Gordon, S. C., Galan, M. V., Tung, B. Y., Ioannou, G. N., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00008 · Cited by 191
Cancer- and Chemotherapy-Induced Anemia
_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0042 · Cited by 191
Regulation of Hepcidin and Iron-Overload Disease
Lee, P. L., & Beutler, E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092205 · Cited by 174
Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli
Huang, H., Constante, M., Layoun, A., & Santos, M. M. (2009) · Blood · doi:10.1182/blood-2008-08-173641 · Cited by 166
Adams, P. C., & Barton, J. C. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61782-6 · Cited by 162
Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease
Ballas, S. K. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90058-7 · Cited by 153
The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores
Wood, J. C., Kang, B. P. S., Thompson, A. A., Giardina, P. J., Harmatz, P., Glynos, T., Paley, C. S., & Coates, T. D. (2010) · Blood · doi:10.1182/blood-2009-11-250308 · Cited by 145
Tamary, H., Shalev, H., Perez-Avraham, G., Zoldan, M., Levi, I., Swinkels, D. W., Tanno, T., & Miller, J. L. (2008) · Blood · doi:10.1182/blood-2008-06-165738 · Cited by 135
Jensen, P. D. Ø., Jensen, F. T., Christensen, T., Nielsen, J. L., & Ellegaard, J. (2002) · Blood · doi:10.1182/blood-2002-06-1704 · Cited by 121
Múñoz, M., Breymann, C., García‐Erce, J. A., Gómez‐Ramírez, S., Colet, J. C., & Bisbe, E. (2007) · Vox Sanguinis · doi:10.1111/j.1423-0410.2007.01014.x · Cited by 118
Self-citationThe Comparative Safety of Intravenous Iron Dextran, Iron Saccharate, and Sodium Ferric Gluconate
Fishbane, S., & Kowalski, E. A. (2000) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2000.00104.x · Cited by 106
Thomas, L., Franck, S., Messinger, M., Linssen, J., Thomé, M., & Thomas, C. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.207 · Cited by 96 · cited 1×
“The Sysmex XE-2100 haematology analyser (Sysmex, Mundelein, Illinois, USA) determines RET-Y, which can be considered as the reticulocyte Hb equivalent, as well as RBC-Y, which can be considered as the erythrocyte Hb equivalent.”
Mavrogeni, S. I., Markussis, V., Kaklamanis, L., Tsiapras, D. P., PARASKEVAIDIS, I. A., Karavolias, G., Karagiorga, M., Douskou, M., Cokkinos, D. V., & Kremastinos, D. T. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00474.x · Cited by 96
Non-invasive assessment of tissue iron overload
Fischer, R., & Harmatz, P. (2009) · Hematology · doi:10.1182/asheducation-2009.1.215 · Cited by 89
Delea, T. E., Sofrygin, O., Thomas, S. K., Baladi, J., Phatak, P. D., & Coates, T. D. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725040-00005 · Cited by 88
Kannengiesser, C., Jouanolle, A., Hetet, G., Mosser, A., Muzeau, F., Henry, D., Bardou‐Jacquet, E., Mornet, M., Brissot, P., Deugnier, Y., et al. (2009) · Haematologica · doi:10.3324/haematol.2008.000125 · Cited by 87
Shander, A., & Sazama, K. J. (2010) · Transfusion · doi:10.1111/j.1537-2995.2009.02551.x · Cited by 77
Safety of intravenous iron in clinical practice: implications for anemia management protocols.
Aronoff, G. R. (2004) · PubMed · doi:10.1097/01.asn.0000143815.15433.87 · Cited by 71
Canals, C., Remacha, A. F., Sardà, M. P., Piazuelo, J., Royo, T., & Romero, M. R. (2005) · PubMed · Cited by 62
Iron status and iron supplementation in peritoneal dialysis patients
Vychytil, A., & Haag–Weber, M. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055suppl.69071.x · Cited by 59
High-Molecular Weight Iron Dextran: A Wolf in Sheep's Clothing?
Rodgers, G. M., Auerbach, M., Cella, D., Chertow, G. M., Coyne, D. W., Glaspy, J. A., & Henry, D. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030255 · Cited by 56
Gattermann, N. (2007) · Leukemia Research · doi:10.1016/s0145-2126(07)70461-7 · Cited by 54
Karnon, J. D., Tolley, K. H., Oyee, J., Jewitt, K., Ossa, D., & Akehurst, R. L. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802077442 · Cited by 47
Rombout‐Sestrienkova, E., van Noord, P. A. H., van Deursen, C. T. B. M., Sybesma, B. J. P. H., Nillesen-Meertens, A. E. L., & Koek, G. H. (2007) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2007.03.005 · Cited by 43
Bach, V., Remacha, A. F., Altés, A., Barceló, M. J., Molina, M. A., & Baiget, M. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.09.001 · Cited by 29
Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines.
Mittelman, M., Lugassy, G., Merkel, D. G., Tamary, H., Sarid, N., Rachmilewitz, E. A., & Hershko, C. (2008) · PubMed · Cited by 28
Anemia management in chronic kidney disease: Intravenous iron steps forward
Coyne, D. W., & Auerbach, M. (2010) · American Journal of Hematology · doi:10.1002/ajh.21682 · Cited by 23
The Relevance of Iron in Erythropoietin-Stimulated Erythropoiesis
Goodnough, L. T. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.08.003 · Cited by 13
Cited by
International consensus statement on the peri‐operative management of anaemia and iron deficiency
Muñoz, M., Acheson, A. G., Auerbach, M., Besser, M., Habler, O., Kehlet, H., Liumbruno, G. M., Lasocki, S., Meybohm, P., Rao Baikady, R., et al. (2017) · Anaesthesia · doi:10.1111/anae.13773 · Cited by 876
Self-citationIron Absorption: Factors, Limitations, and Improvement Methods
Piskin, E., Cianciosi, D., Gulec, S., Tomas, M., & Capanoglu, E. (2022) · ACS Omega · doi:10.1021/acsomega.2c01833 · Cited by 543
Lin, C.-H., Chen, C.-H., Lin, Z.-C., & Fang, J.-Y. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2017.02.001 · Cited by 298
Muñoz, M., Acheson, A. G., Bisbe, E., Butcher, A., Gómez‐Ramírez, S., Khalafallah, A. A., Kehlet, H., Kietaibl, S., Liumbruno, G. M., Meybohm, P., et al. (2018) · Anaesthesia · doi:10.1111/anae.14358 · Cited by 255
Self-citationA Short Review of Iron Metabolism and Pathophysiology of Iron Disorders
Yiannikourides, A., & Latunde-Dada, G. (2019) · Medicines · doi:10.3390/medicines6030085 · Cited by 253
Metadata
- Authors
- Muñoz, M., García-Erce, J. A., & Remacha, Á. F.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2010-12-20
- Volume
- 64
- Issue
- 4
- Pages
- 287-296
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W2144207984
- Cited by
- 292
- References
- 55
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.